Cytomegalovirus haemorrhagic colitis complicating COVID‐19 in an immunocompetent critically ill patient: A case report
Authors:
Open Access
- 5 December 2020
- journal article
- case report
- Published by Wiley in Clinical Case Reports
- Vol. 9 (5)
Abstract
Suspicion threshold for opportunistic coinfections should be lowered in severe COVID‐19. Serum CMV polymerase chain reaction and colonoscopy should be discussed in presence of persistent digestive disturbances.Keywords
All Related Versions
This publication has 18 references indexed in Scilit:
- The clinical course and its correlated immune status in COVID-19 pneumoniaJournal of Clinical Virology, 2020
- COVID‐19 associated pulmonary aspergillosisMycoses, 2020
- High Prevalence of Putative Invasive Pulmonary Aspergillosis in Critically Ill COVID-19 PatientsSSRN Electronic Journal, 2020
- Hematologic parameters in patients with COVID‐19 infectionAmerican Journal of Hematology, 2020
- Gut Bacteria—Not for the Faint of HeartCell Host & Microbe, 2020
- Cytomegalovirus infection and outcome in immunocompetent patients in the intensive care unit: a systematic review and meta-analysisBMC Infectious Diseases, 2018
- Symptomatic cytomegalovirus gastrointestinal infection with positive quantitative real-time PCR findings in apparently immunocompetent patients: a case seriesClinical Microbiology and Infection, 2015
- Approach to invasive pulmonary aspergillosis in critically ill patientsCurrent Opinion in Infectious Diseases, 2014
- Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjectsJournal of Experimental Medicine, 2005
- Human cytomegalovirus infections in nonimmunosuppressed critically ill patientsCritical Care Medicine, 2001